Titan Medical to Present at the 28th Annual Oppenheimer Healthcare Conference
March 15 2018 - 7:30AM
Titan Medical Inc. (TSX:TMD) (OTCQB:TITXF)
(“Titan” or the “Company”), a medical device company focused on the
design and development of a robotic surgical system for application
in minimally invasive surgery (“MIS”), today announced that David
McNally, President and CEO of the Company, will present a corporate
overview at the 28th Annual Oppenheimer Healthcare Conference on
Tuesday, March 20 at 1:00 p.m. EDT. The conference will be held
March 20-21, 2018 at The Westin New York Grand Central in New York
City.
A copy of the Company’s presentation has been
posted to the Investors section of its website. The presentation
will not be webcast.
About Titan Medical Inc.
Titan Medical Inc. is focused on research and
development through to the planned commercialization of
computer-assisted robotic surgical technologies for application in
minimally invasive surgery. The Company is developing the SPORT
Surgical System, a single-port robotic surgical system. The SPORT
Surgical System is comprised of a surgeon-controlled patient cart
that includes a 3D high-definition vision system and
multi-articulating instruments for performing MIS procedures, and a
surgeon workstation that provides an advanced ergonomic interface
to the patient cart and a 3D endoscopic view inside the patient’s
body. Titan intends to pursue a broad set of surgical indications
for the SPORT Surgical System, including general abdominal,
gynecologic and urologic procedures.
For more information, please visit the Company’s
website at www.titanmedicalinc.com.
Contacts:
LHAKim Sutton Golodetz(212)
838-3777kgolodetz@lhai.com orBruce Voss(310)
691-7100bvoss@lhai.com
Titan Medical (TSX:TMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Titan Medical (TSX:TMD)
Historical Stock Chart
From Apr 2023 to Apr 2024